J. E. Megías-rekin lankidetzan egindako argitalpenak (15)

2021

  1. Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 62, Núm. 3, pp. 659-668

  2. Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia

    Pharmacogenetics and Genomics, Vol. 31, Núm. 6, pp. 133-139

2018

  1. Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

    Pharmacogenomics Journal, Vol. 18, Núm. 2, pp. 301-307

  2. Pharmacogenetics of metabolic genes of anthracyclines in acute myeloid leukemia

    Current Drug Metabolism, Vol. 19, Núm. 1, pp. 55-74

2017

  1. Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 58, Núm. 5, pp. 1197-1206

  2. Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

    Pharmacogenetics and Genomics, Vol. 27, Núm. 7, pp. 270-274

  3. Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

    Leukemia and Lymphoma, Vol. 58, Núm. 12, pp. 2880-2894

2016

  1. A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia

    Pharmacogenomics Journal, Vol. 16, Núm. 1, pp. 30-40

  2. Pharmacogenomics and the treatment of acute myeloid leukemia

    Pharmacogenomics, Vol. 17, Núm. 11, pp. 1245-1272

  3. Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: A systematic review and meta-analysis

    Pharmacogenomics Journal

2015

  1. Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation

    Pharmacogenomics, Vol. 16, Núm. 9, pp. 971-979

  2. Effect of CYP3A5∗3 on kidney transplant recipients treated with tacrolimus: A systematic review and meta-analysis of observational studies

    Pharmacogenomics Journal, Vol. 15, Núm. 1, pp. 38-48

  3. Impact of single nucleotide polymorphisms (SNPs) on immunosuppressive therapy in lung transplantation

    International Journal of Molecular Sciences, Vol. 16, Núm. 9, pp. 20168-20182

  4. Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

    Pharmacogenomics Journal, Vol. 15, Núm. 2, pp. 109-118

2014

  1. SNPs and taxane toxicity in breast cancer patients

    Pharmacogenomics, Vol. 15, Núm. 15, pp. 1845-1858